Matinas BioPharma updates corporate presentation; no material new information disclosed

Matinas BioPharma Holdings, Inc.

Furnished updated corporate presentation dated March 28, 2024 under Regulation FD.
Presentation to be used at conferences and investor meetings; specific content not provided.
No financial results, guidance, or operational milestones disclosed in the filing.

item 7.01 item 9.01

Matinas BioPharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-011625

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.